The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Paratek Pharmaceuticals Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving ...
read more
The PACIFIC Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) demonstrated a sustained, clinically meaningful overall survival (OS) and ...
read more
Regeneron Pharmaceuticals Inc. announced the U.S. FDA updated the Emergency Use Authorization (EUA) for REGEN-COV™, lowering the dose to 1,200 mg (600...
read more
Akoya Biosciences Inc. and The Spatial Biology Company® announced a collaboration with AstraZeneca to advance new multiplex immunofluorescence (mIF) ...
read more
Aeterna Zentaris Inc, a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic ...
read more
The U.S. Food and Drug Administration approved Tembexa (brincidofovir) to treat smallpox. Although the World Health Organization declared smallpox, a ...
read more
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, ...
read more
iTeos Therapeutics and GlaxoSmithKline plc agree to co-develop and co-commercialize EOS-448, an anti-TIGIT monoclonal antibody currently in phase I ...
read more
Novavax Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced data from the first co-...
read more
Jounce Therapeutics Inc., a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers,...
read more
MannKind Corporation and United Therapeutics Corporation announced that the U.S. Food and Drug Administration (FDA) accepted for priority review of ...
read more
The U.S. FDA approved a nasal antihistamine for nonprescription use through a process called a partial prescription to nonprescription switch. The FDA...
read more
Hope Biosciences Stem Cell Research Foundation (HBSCRF) has received FDA authorization for a Phase II clinical trial to assess the efficacy and safety...
read more
The U.S. FDA approved Pradaxa (dabigatran etexilate) oral pellets to treat children 3 months to less than 12 years old with venous thromboembolism (a ...
read more
Blackstone Life Sciences has committed $250 million towards the launch of a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-...
read more